TP53 and melanoma: Recent studies have provided a characterization of the genetic abnormalities occurring in desmoplastic melanoma (Figure 5): BRAF and NRAS mutations were absent; NF1 (52%) and TP53 (48%) mutations were particularly frequent; genes involved in MAPK pathway, cell-cycle, TP53 pathway, and epigenetic control are frequently mutated [152].